TG Therapeutics, Inc. (0VGI.L)

USD 31.97

(-5.69%)

Gross Profit Summary of TG Therapeutics, Inc.

  • TG Therapeutics, Inc.'s latest annual gross profit in 2023 was 219.1 Million USD , up 8594.76% from previous year.
  • TG Therapeutics, Inc.'s latest quarterly gross profit in 2024 Q2 was 65.09 Million USD , up 12.32% from previous quarter.
  • TG Therapeutics, Inc. reported a annual gross profit of 2.52 Million USD in annual gross profit 2022, down -57.28% from previous year.
  • TG Therapeutics, Inc. reported a annual gross profit of 5.89 Million USD in annual gross profit 2021, up 2757.21% from previous year.
  • TG Therapeutics, Inc. reported a quarterly gross profit of 65.09 Million USD for 2024 Q2, up 12.32% from previous quarter.
  • TG Therapeutics, Inc. reported a quarterly gross profit of 74.53 Million USD for 2024 Q3, up 14.52% from previous quarter.

Annual Gross Profit Chart of TG Therapeutics, Inc. (2023 - 1996)

Historical Annual Gross Profit of TG Therapeutics, Inc. (2023 - 1996)

Year Gross Profit Gross Profit Growth
2023 219.1 Million USD 8594.76%
2022 2.52 Million USD -57.28%
2021 5.89 Million USD 2757.21%
2020 -222 Thousand USD -70.77%
2019 -130 Thousand USD -303.13%
2018 64 Thousand USD -8.61%
2017 70.02 Thousand USD -21.69%
2016 89.42 Thousand USD -41.32%
2015 152.38 Thousand USD 0.0%
2014 152.38 Thousand USD 0.0%
2013 152.38 Thousand USD 699.98%
2012 19.04 Thousand USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD -100.0%
2002 500 Thousand USD -20.55%
2001 629.35 Thousand USD -51.57%
2000 1.29 Million USD 224.9%
1999 400 Thousand USD -87.5%
1998 3.2 Million USD 1500.0%
1997 200 Thousand USD 100.0%
1996 100 Thousand USD 0.0%

Peer Gross Profit Comparison of TG Therapeutics, Inc.

Name Gross Profit Gross Profit Difference
Thermo Fisher Scientific Inc. 15.22 Billion USD 98.561%
Dynavax Technologies Corporation 182.11 Million USD -20.312%
Illumina, Inc. 2.74 Billion USD 92.015%
IQVIA Holdings Inc. 5.23 Billion USD 95.818%
Biogen Inc. 7.3 Billion USD 96.999%
Iovance Biotherapeutics, Inc. -9.56 Million USD 2390.487%
Mettler-Toledo International Inc. 2.16 Billion USD 89.899%
Sarepta Therapeutics, Inc. 1.09 Billion USD 79.953%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 58.165%
Waters Corporation 1.76 Billion USD 87.559%
Perrigo Company plc 1.68 Billion USD 86.961%
uniQure N.V. 2.21 Million USD -9792.009%
Agios Pharmaceuticals, Inc. 17.31 Million USD -1165.131%
Amicus Therapeutics, Inc. 362.03 Million USD 39.478%
Atara Biotherapeutics, Inc. -313 Thousand USD 70102.556%
bluebird bio, Inc. -4.03 Million USD 5536.923%
Cara Therapeutics, Inc. 14.79 Million USD -1381.06%
Imunon, Inc. -720 Thousand USD 30531.455%
Myriad Genetics, Inc. 476.4 Million USD 54.008%
Neurocrine Biosciences, Inc. 1.84 Billion USD 88.14%
Nektar Therapeutics 53.47 Million USD -309.716%
Editas Medicine, Inc. -99.52 Million USD 320.147%
Verastem, Inc. -62 Thousand USD 353500.0%
Walgreens Boots Alliance, Inc. 26.52 Billion USD 99.174%
Corbus Pharmaceuticals Holdings, Inc. -31.16 Million USD 802.998%
Heron Therapeutics, Inc. 10.04 Million USD -2081.916%
Unity Biotechnology, Inc. -19.69 Million USD 1212.28%
BioMarin Pharmaceutical Inc. 1.9 Billion USD 88.494%
Sangamo Therapeutics, Inc. -45.32 Million USD 583.415%
Evolus, Inc. 140.52 Million USD -55.92%
Adicet Bio, Inc. -6.09 Million USD 3693.112%
Aclaris Therapeutics, Inc. -85.21 Million USD 357.121%
Regeneron Pharmaceuticals, Inc. 11.3 Billion USD 98.061%
Esperion Therapeutics, Inc. 73.06 Million USD -199.873%
FibroGen, Inc. 128.9 Million USD -69.978%
Agilent Technologies, Inc. 3.46 Billion USD 93.677%
OPKO Health, Inc. 318.12 Million USD 31.126%
Homology Medicines, Inc. -7.22 Million USD 3130.959%
Geron Corporation -123.5 Million USD 277.411%
Alnylam Pharmaceuticals, Inc. 1.51 Billion USD 85.565%
Exelixis, Inc. 1.75 Billion USD 87.534%
Viking Therapeutics, Inc. -292 Thousand USD 75136.986%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. -398.79 Million USD 154.943%
Zoetis Inc. 5.83 Billion USD 96.244%
Axsome Therapeutics, Inc. 244.53 Million USD 10.398%
Abeona Therapeutics Inc. 302 Thousand USD -72452.318%
Vertex Pharmaceuticals Incorporated 8.6 Billion USD 97.454%
Kala Pharmaceuticals, Inc. -303 Thousand USD 72412.871%
Ionis Pharmaceuticals, Inc. 778.51 Million USD 71.856%
Corcept Therapeutics Incorporated 475.89 Million USD 53.959%
Halozyme Therapeutics, Inc. 636.89 Million USD 65.597%
Blueprint Medicines Corporation 236.58 Million USD 7.387%
Insmed Incorporated 239.63 Million USD 8.566%
Incyte Corporation 3.44 Billion USD 93.632%
Emergent BioSolutions Inc. 343.9 Million USD 36.287%